VISION
Our vision is to integrate digital therapies into everyday care, improve access to effective treatments and have a lasting and positive impact on patients' quality of life.
01
Evidence-based approach
We work with leading scientists, doctors, therapists and experts to implement proven therapies in a digital format. We also demonstrate the efficacy of our treatments in randomized controlled trials.
02
Focus on adherence
We promote therapy compliance through user-friendly applications, gamification elements, quizzes, intelligent notifications and targeted support to make it easy for patients to stay adherent and achieve therapy success.
03
Learning-based therapy
We integrate learning content and interactive quizzes into our therapies because we are convinced of the positive effect of learning on health competency. This helps patients to achieve their health goals and sustainably improves therapy outcomes.
04
Personalized treatment
Our therapies use patient input and entries to tailor the therapy to the individual needs of each person. This enables optimal results and a targeted approach to therapeutic challenges.
05
IT security and data protection
Our company is certified in information security according to DIN EN ISO/IEC 27001:2022 and works according to the highest data protection and cyber security standards.
ABOUT US
Digital Therapeutics. Made in Bremen.
PLS AG develops innovative digital therapeutics (DTx) to improve access to effective treatments and sustainably improve the health and quality of life of patients.
PLS AG is currently focusing on the development of digital therapeutics for various healthcare areas to provide millions of people in Germany with guideline-based and drug-free treatments without long waiting times. PLS AG's digital therapeutics are approved as medical devices, prove their effectiveness in clinical studies, and comply with the highest data protection and information security standards.
MISSION
Easy access to guideline-based therapy. Without waiting times.
Our digital therapies (DTx) provide an easy access to evidence-based treatments. They close gaps in care and offer patients quick, low-risk support. DTx have the potential to reduce the burden on the healthcare system and make care more efficient and accessible.
TEAM
The PLS Team
Co-Founder
Nora Heim
Co-Founder
Aurel Groh
_edited.jpg)
Co-Founder
Carl Schütte